CD40LG and COVID-19: We analyzed the total Ab, IgM, IgG, and IgA, but there were no significant differences in antibody titers between re-positive recovered COVID-19 patients and non-re-positives (Figure S1), suggesting that all the 182 recovered patients, including the 20 cases that re-tested positive, are antibody carriers.